164 Chapter 4 Table S1: Overview of the opportunities, threats, and mitigating measures per theme (indepth version of Table 3 in the main manuscript) (Continued) 3. Precision medicine - This includes opportunities/ threats related to personalized blood management (e.g. personalized donation or transfusion trigger) and on specialized patients who need specialized products. Opportunities • Improved use and effectiveness of donations/ products/patient care Threats Insufficient availability of specific donors/products More complex logistics Mitigating measures • Continuously consult with stakeholders (E.g. hospitals, patients, donors) to identify their true needs, concerns, expectations • Increasing knowledge and research activities on precision medicine for donors and patients and combining these initiatives 4. Commercialization / Open EU market - This includes opportunities and threats related to blood products in an open market, open borders, and related costs and methods for commercialization. Opportunities • There is external drive to become more innovative • Expanding Sanquin’s operations and services internationally • International cooperation/merges increases self-sufficiency and sensitivity to market/demand changes Opportunity and threat • Competition from other blood banks legalized in the Netherlands or from foreign products • Maintaining Sanquin’s high price only if the added value is recognized by the customer Threats • Continuity of the company is at stake when no competitive edge is found • Costs of blood products become too high Mitigating measures • Actively monitor development of products and prices in other countries and review our own position therein • Ensure that there is a competitive edge within the product range as compared to comparable blood banks • Demonstrate that the added value of Sanquin’s products and services is recognized and appreciated by its customers (create transparency on the additional research and services that is included per product) • Invest in innovations in order to maintain a competitive edge with other blood banks • Explore the potential of developing alternative commercial products and/or services
RkJQdWJsaXNoZXIy MTk4NDMw